Global Retirement Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.67M | Buy |
54,502
+16,765
| +44% | +$782K | 0.05% | 353 |
|
|
2025
Q3 | $1.63M | Sell |
37,737
-6,784
| -15% | -$265K | 0.04% | 401 |
|
|
2025
Q2 | $1.71M | Buy |
+44,521
| New | +$1.7M | 0.04% | 375 |
|
|
2024
Q4 | $1.25M | Sell |
36,847
-3,263
| -8% | -$117K | 0.04% | 400 |
|
|
2024
Q3 | $1.64M | Buy |
40,110
+1,664
| +4% | +$68.1K | 0.05% | 332 |
|
|
2024
Q2 | $1.48M | Buy |
38,446
+5,341
| +16% | +$225K | 0.05% | 338 |
|
|
2024
Q1 | $1.42M | Buy |
33,105
+983
| +3% | +$40.5K | 0.05% | 300 |
|
|
2023
Q4 | $1.28M | Buy |
32,122
+2,197
| +7% | +$78.9K | 0.05% | 294 |
|
|
2023
Q3 | $1.08M | Buy |
29,925
+21,216
| +244% | +$753K | 0.05% | 292 |
|
|
2023
Q2 | $310K | Buy |
8,709
+966
| +12% | +$34.6K | 0.02% | 562 |
|
|
2023
Q1 | $285K | Buy |
7,743
+3,254
| +72% | +$114K | 0.02% | 557 |
|
|
2022
Q4 | $158K | Buy |
4,489
+886
| +25% | +$29.5K | 0.01% | 672 |
|
|
2022
Q3 | $120K | Buy |
3,603
+555
| +18% | +$21K | 0.01% | 712 |
|
|
2022
Q2 | $166K | Buy |
3,048
+8
| +0.3% | +$442 | 0.01% | 603 |
|
|
2022
Q1 | $171K | Buy |
+3,040
| New | +$165K | 0.01% | 592 |
|
|
2021
Q4 | – | Sell |
-2,266
| Closed | -$108K | – | 869 |
|
|
2021
Q3 | $108K | Sell |
2,266
-4,088
| -64% | -$205K | 0.01% | 626 |
|
|
2021
Q2 | $316K | Buy |
6,354
+4,086
| +180% | +$196K | 0.03% | 374 |
|
|
2021
Q1 | $101K | Buy |
2,268
+463
| +26% | +$21K | 0.01% | 570 |
|
|
2020
Q4 | $83K | Sell |
1,805
-753
| -29% | -$34.6K | 0.01% | 576 |
|
|
2020
Q3 | $120K | Buy |
2,558
+32
| +1% | +$1.6K | 0.02% | 450 |
|
|
2020
Q2 | $129K | Buy |
2,526
+412
| +19% | +$21.1K | 0.02% | 433 |
|
|
2020
Q1 | $100K | Sell |
2,114
-240
| -10% | -$12.8K | 0.02% | 431 |
|
|
2019
Q4 | $138K | Sell |
2,354
-152
| -6% | -$8.46K | 0.02% | 430 |
|
|
2019
Q3 | $134K | Sell |
2,506
-257
| -9% | -$13.2K | 0.02% | 430 |
|
|
2019
Q2 | $138K | Sell |
2,763
-50
| -2% | -$2.51K | 0.03% | 402 |
|
|
2019
Q1 | $147K | Buy |
2,813
+336
| +14% | +$16.8K | 0.04% | 343 |
|
|
2018
Q4 | $118K | Buy |
2,477
+715
| +41% | +$35.2K | 0.03% | 361 |
|
|
2018
Q3 | $88K | Buy |
1,762
+53
| +3% | +$2.69K | 0.02% | 429 |
|
|
2018
Q2 | $86K | Buy |
1,709
+571
| +50% | +$28.8K | 0.02% | 412 |
|
|
2018
Q1 | $56K | Sell |
1,138
-212
| -16% | -$9.87K | 0.02% | 496 |
|
|
2017
Q4 | $60K | Hold |
1,350
| – | – | 0.02% | 458 |
|
|
2017
Q3 | $69K | Buy |
1,350
+452
| +50% | +$22.9K | 0.03% | 371 |
|
|
2017
Q2 | $48K | Buy |
898
+28
| +3% | +$1.49K | 0.02% | 417 |
|
|
2017
Q1 | $46K | Buy |
870
+254
| +41% | +$12.9K | 0.03% | 392 |
|
|
2016
Q4 | $30K | Buy |
+616
| New | +$30.4K | 0.02% | 435 |
|
Other funds holding GSK
JEST
